Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 17, 1999

View Archived Issues

PowderJect, Ares-Serono Enter $100M Deal For Dry Vaccines

British Biotech's Marimastat Fails In Pivotal Cancer Study

Genetically Modified Milk Could Be Next On Shelves

Biota's Influenza Drug Wins Pair Of Approvals

Genset Reports Highest Quarterly Loss Of Year

European Parliament Calls For Amended GMO Rules

Cerep Revenues Hit Slump After Several Contracts End

EU Backs Biosafety Protocol, Warns Of 'Extreme Positions'

GMO Soya Crops Will Outdo Other Variety, Says Professor

Trinity Biotech's EPS Up 67 Percent For Year

Virax Shares Valued Higher After Patents

Monsanto's GMO Cotton Plan Still Stymied By EU

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...